A dose-effect study of beraprost sodium in intermittent claudication

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 6, 1996, Pages 788-793

  Lievre, Michel ^a,c   Azoulay, S ^b   Lion, L ^a   Morand, S ^b   Girre, J P ^b   Boissel, J P ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b Laboratoires Houdé   (France)

^c Service de Pharmacologie Clinique   (France)

Author keywords

Beraprost sodium; Dose effect study; Epoprostenol analogue; Intermittent claudication; Randomized clinical trial

Indexed keywords

BERAPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN DISEASE; TABLET; TREADMILL EXERCISE; TREATMENT OUTCOME; WALKING;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPOPROSTENOL; EXERCISE TEST; FEMALE; GASTROINTESTINAL DISEASES; HEADACHE; HUMANS; INTERMITTENT CLAUDICATION; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; VASODILATOR AGENTS;

EID: 0029891069     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199606000-00004     Document Type: Article

References (7)

1. 2, epoprostenol and other eicosanoids in the cardiovascular system. Therapie 1991;46:217-21.
2. 2) in 108 patients with ischaemic peripheral vascular disease. Prostaglandins 1990;39:657-64.
3. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992;43: 889-924.
4. Kato R, Uji Y, Matsumoto K. Phase I study of beraprost sodium (TRK-100), a epoprostenol derivative: repeated oral administration for 10 days. Jpn J Clin Pharmacol Ther 1989; 20:529-39.
5. Demolis JL, Robert A, Mouren M, Funck-Brentano C, JailIon P. Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable epoprostenol analogue, in healthy volunteers. J Cardiovasc Pharmacol 1993;22:711-6.
6. Dormandy J. Use of prostacyclin analogue iloprost in the treatment of patients with critical limb ischaemia. Therapie 1991;46:319-22.
7. 2 analogue. Br J Pharmacol 1986; 89:703-11.